Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1766507rdf:typepubmed:Citationlld:pubmed
pubmed-article:1766507lifeskim:mentionsumls-concept:C1848569lld:lifeskim
pubmed-article:1766507lifeskim:mentionsumls-concept:C0011644lld:lifeskim
pubmed-article:1766507lifeskim:mentionsumls-concept:C0085240lld:lifeskim
pubmed-article:1766507pubmed:issue4lld:pubmed
pubmed-article:1766507pubmed:dateCreated1992-2-19lld:pubmed
pubmed-article:1766507pubmed:abstractTextA 47-year-old woman with overlap scleroderma-polymyositis syndrome and positive circulating lupus anticoagulant developed scleroderma nephropathy, characterized by rapidly progressive renal failure caused by thrombotic microangiopathy with widespread thrombi in small arteries and glomeruli. The possible relationship between lupus anticoagulant and the development of thrombosis at the small renal vessels level with the triggering of the scleroderma crisis is discussed.lld:pubmed
pubmed-article:1766507pubmed:languageenglld:pubmed
pubmed-article:1766507pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1766507pubmed:citationSubsetIMlld:pubmed
pubmed-article:1766507pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1766507pubmed:statusMEDLINElld:pubmed
pubmed-article:1766507pubmed:issn0028-2766lld:pubmed
pubmed-article:1766507pubmed:authorpubmed-author:QueredaCClld:pubmed
pubmed-article:1766507pubmed:authorpubmed-author:GonzaloAAlld:pubmed
pubmed-article:1766507pubmed:authorpubmed-author:PardoAAlld:pubmed
pubmed-article:1766507pubmed:authorpubmed-author:PascualJJlld:pubmed
pubmed-article:1766507pubmed:authorpubmed-author:MampasoFFlld:pubmed
pubmed-article:1766507pubmed:authorpubmed-author:OrtuñoJJlld:pubmed
pubmed-article:1766507pubmed:issnTypePrintlld:pubmed
pubmed-article:1766507pubmed:volume59lld:pubmed
pubmed-article:1766507pubmed:ownerNLMlld:pubmed
pubmed-article:1766507pubmed:authorsCompleteYlld:pubmed
pubmed-article:1766507pubmed:pagination651-3lld:pubmed
pubmed-article:1766507pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:1766507pubmed:meshHeadingpubmed-meshheading:1766507-...lld:pubmed
pubmed-article:1766507pubmed:meshHeadingpubmed-meshheading:1766507-...lld:pubmed
pubmed-article:1766507pubmed:meshHeadingpubmed-meshheading:1766507-...lld:pubmed
pubmed-article:1766507pubmed:meshHeadingpubmed-meshheading:1766507-...lld:pubmed
pubmed-article:1766507pubmed:meshHeadingpubmed-meshheading:1766507-...lld:pubmed
pubmed-article:1766507pubmed:meshHeadingpubmed-meshheading:1766507-...lld:pubmed
pubmed-article:1766507pubmed:meshHeadingpubmed-meshheading:1766507-...lld:pubmed
pubmed-article:1766507pubmed:meshHeadingpubmed-meshheading:1766507-...lld:pubmed
pubmed-article:1766507pubmed:meshHeadingpubmed-meshheading:1766507-...lld:pubmed
pubmed-article:1766507pubmed:year1991lld:pubmed
pubmed-article:1766507pubmed:articleTitleThrombotic microangiopathic nephropathy in scleroderma and lupus anticoagulant.lld:pubmed
pubmed-article:1766507pubmed:affiliationServicio de Nefrologia, Hospital Ramón y Cajal, Madrid, Spain.lld:pubmed
pubmed-article:1766507pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1766507pubmed:publicationTypeCase Reportslld:pubmed